Ligand Reports Third Quarter 2022 Financial Results
Go back to Ligand Reports Third Quarter 2022 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 289.92 +1.17 (0.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $288.75 | 52 Week High | $139.79 | |||
| Open | $290.38 | 52 Week Low | $82.07 | |||
| Day High | $294.54 | P/E | 674.23 | |||
| Day Low | $287.81 | EPS | $0.43 | |||
| Volume | 193,220 | |||||
| (NASDAQ: VRNA) | Delayed: 106.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.91 | 52 Week High | $ | |||
| Open | $106.91 | 52 Week Low | $ | |||
| Day High | $106.91 | P/E | N/A | |||
| Day Low | $106.91 | EPS | $ | |||
| Volume | 372,026 | |||||
